Drug Screening Market is Expected to Reach $19.5 billion | MarketsandMarkets™

Chicago, June 05, 2024 (GLOBE NEWSWIRE) -- Drug Screening market in terms of revenue was estimated to be worth $9.1 billion in 2024 and is poised to reach $19.5 billion by 2029, growing at a CAGR of 16.6% from 2024 to 2029 according to a latest report published by MarketsandMarkets™.

Growth in this market is attributed to the increasing drug & alcohol consumption and the implementation of stringent laws mandating drug & alcohol testing. However, bans on workplace drug testing in specific countries are some key factors that may hinder market growth.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773

Drug Screening Market Scope:

Report Coverage	Details
Market Revenue in 2024	$9.1 billion
Estimated Value by 2029	$19.5 billion
Growth Rate	Poised to grow at a CAGR of 16.6%
Market Size Available for	2018–2029
Forecast Period	2024–2029
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Product & Service, Sample type, Drug Type, End User, and Region
Geographies Covered	North America (US and Canada), Europe (Germany, UK, France, Italy, Spain and Rest of Europe), Asia Pacific (Japan, China, India, and RoPAC), Latin America (Brazil, Mexico, Rest of Latin America) Middle East & Africa (GCC Countries, Rest of Middle East & Africa)
Report Highlights	Updated financial information / product portfolio of players
Key Market Opportunity	Oral Fluid Testing
Key Market Driver	Growing drug and alcohol consumption

By drug screening product, rapid testing device market is divided into urine testing and oral fluid testing devices. Urine testing devices market is expected to account for the largest share in the market in 2024. However, the oral fluid testing devices is expected to register the highest growth rate during the 2024-2029. Rapid urine testing provides results within minutes. It utilizes immunoassay technology, which is the same as laboratory-based instrument screening. Rapid urine tests are used by employers for random testing and by criminal justice systems, law enforcement agencies, drug treatment centers, hospitals. The urine testing devices market is categorized into drug testing cups, dip cards, and cassettes. The drug testing cups segment accounted for the largest market share in 2023.

By sample type, drug screening market is divided into urine, oral fluid (saliva), hair, breath, and other samples. The urine sample is accounted for the largest share in 2023. However, the oral fluid samples segment is expected to register the highest CAGR during the forecast period. The high growth rate of this segment is largely due to the growing preference for oral fluid samples and their benefits, such as easy collection, no specific requirement for sample collection, and lower risk of sample adulteration.

By end user, the drug screening is divided into workplaces, criminal justice systems & law enforcement, drug treatment centers, pain management centers, schools & colleges, hospitals, individual users, drug testing laboratories, and other end users. The drug testing laboratories testing segment accounted for the largest market share in 2023, owing to growing drug abuse cases & rising screening tests.

The global drug screening market is segmented into North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. In 2023, North America dominated the global drug screening market followed by Europe. On the other hand, Asia Pacific is expected to grow at the highest growth rate during the forecast period. The high growth of this regional segment is attributed due to the expanding illegal consumption of drugs, the developing healthcare infrastructure and soaring adoption of stringent regulatory guidelines for drug testing.

Buy a Drug Screening Industry Report (533 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=162987773

Prominent Players of Drug Screening Market

• Labcorp (US)
• Quest Diagnostics (US)
• Abbott (US)
• Thermo Fisher Scientific Inc. (US)
• Alfa Scientific Designs, Inc. (US)
• OraSure Technologies Inc. (US)
• Siemens Healthineers AG (Germany)
• F. Hoffmann-La Roche Ltd (Switzerland)
• MPD Inc. (US)
• Shimadzu Corporation (Japan)
• Lifeloc Technologies, Inc. (US)
• Drägerwerk AG & Co. KGaA (Germany)
• Premier Biotech, Inc. (US)
• Omega Laboratories, Inc. (US)
• Psychemedics Corporation (US)
• Clinical Reference Laboratory, Inc. (US)
• American Bio Medica Corporation (US)
• ACM Global Laboratories (US)
• CareHealth America Corp (US)
• Sciteck, Inc. (US)
• Intoximeters, Inc. (US)
• AccuSourceHR, Inc. (US)
• Cordant Health Solutions (US)
• Intoxalock (US)
• Millennium Health (US)
• and Among others

The study categorizes the Drug screening market into the following segments and subsegments:

By Product and Service

• Drug Screening Product
  • Analytical Instruments
    • Type
      • Breathalyzers
        • Fuel Cell Breathalyzer
        • Semiconductor Breathalyzer
        • Other Breathalyzers
      • Immunoassay Analyzer
      • Chromatography Instruments
    • Modality
      • Handheld
      • Benchtop
  • Rapid Testing Devices
    • Urine Testing Devices
      • Drug Testing Cups
      • Dip Cards
        • Drug Testing Cassettes
      • Oral Fluid Testing Devices
    • Consumables
      • Assay Kits
      • Sample Collection Devices
      • Calibrators & Controls
      • Other Consumables
• Drug Screening Services
  • Laboratory Testing Services
  • On-site services

By Sample Type

• Urine Samples
• Breath Samples
• Oral Fluid Samples
• Hair Samples
• Other Samples

By Drug Type

• Alcohol
• Cannabis
• Cocaine
• Opioids
• Amphetamine and Meth Amphetamine
• Other Drug Type

By End User

• Drug Testing Laboratories
• Workplaces
• Criminal Justice and Law Enforcement Agencies
• Hospitals
• Drug Treatment Centers
• Individual Users
• Pain Management Centers
• Schools and Colleges
• Other end users               

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC countries
  • Rest of middle East & Africa

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773

Key Market Stakeholders:

• Drug and alcohol testing laboratories
• Drug and alcohol testing product manufacturers
• Rapid drug screening device manufacturers
• Law enforcement agencies
• Healthcare providers
• Government agencies
• Research and consulting firms
• Venture capitalists

Report Objectives:

• To define, describe, and forecast the global drug screening market based on the product and service, sample type, drug type, end user and region.
• To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities)
• To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall drug screening market.
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
• To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
• To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies.
• To track and analyze competitive developments such as acquisitions, product and services launches, approvals, expansions, agreements, partnerships, and R&D activities in the drug screening market.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=162987773

Related Reports:

Cannabis Testing Market

Allergy Diagnostics Market

Clinical Chemistry Analyzers Market

Breath Analyzer Market

Hematology Analyzers and Reagents Market

Get access to the latest updates on Drug Screening Companies and Drug Screening Market Share

            About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com